Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Knight

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2008
Multicenter, randomized, double-blind, placebo-controlled study of thalidomide plus dexamethasone compared with dexamethasone as initial therapy for newly diagnosed multiple myelomaS Vincent Rajkumar, Laura Rosiñol, Mohamad Hussein, et al.
Leukemia & Lymphoma|February 2, 2012
Efficacy, safety and quality-of-life associated with lenalidomide plus dexamethasone for the treatment of relapsed or refractory multiple myeloma: the Spanish experienceAdrian Alegre, Albert Oriol-Rocafiguera, Jose Garcia-Larana, et al.
Health and Quality of Life Outcomes|September 10, 2009
Valuation of transfusion-free living in MDS: results of health utility interviews with patientsAgota Szende, Caroline Schaefer, Thomas F Goss, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 10, 2022
Plasma microRNA vary in association with the progression of Alzheimer's diseaseDiane Guévremont, Helen Tsui, Robert Knight, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 16, 2011
Adjusting for patient crossover in clinical trials using external data: a case study of lenalidomide for advanced multiple myelomaK Jack Ishak, J Jaime Caro, Mark T Drayson, et al.
Journal of Cell Science|October 23, 2020
Cell Tracking Profiler - a user-driven analysis framework for evaluating 4D live-cell imaging dataClaire Mitchell, Lauryanne Caroff, Jose Alonso Solis-Lemus, et al.
Depression and Anxiety|February 14, 2015
Changes in neuropsychological function after treatment with metacognitive therapy or cognitive behavior therapy for depressionSamantha J Groves, Richard J Porter, Jennifer Jordan, et al.
The New England Journal of Medicine|October 6, 2006
Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletionAlan List, Gordon Dewald, John Bennett, et al.
The Journal of Surgical Research|December 20, 2021
Antigen Receptor T Cells (CAR-T) Effectively Control Tumor Growth in a Colorectal Liver Metastasis ModelLouis F Chai, John C Hardaway, Kara R Heatherton, et al.
Journal for Immunotherapy of Cancer|August 27, 2020
HITM-SURE: Hepatic immunotherapy for metastases phase Ib anti-CEA CAR-T study utilizing pressure enabled drug deliverySteven C Katz, Ashley E Moody, Prajna Guha, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2008
Multicenter, randomized, double-blind, placebo-controlled study of thalidomide plus dexamethasone compared with dexamethasone as initial therapy for newly diagnosed multiple myelomaS Vincent Rajkumar, Laura Rosiñol, Mohamad Hussein, et al.
Leukemia & Lymphoma|February 2, 2012
Efficacy, safety and quality-of-life associated with lenalidomide plus dexamethasone for the treatment of relapsed or refractory multiple myeloma: the Spanish experienceAdrian Alegre, Albert Oriol-Rocafiguera, Jose Garcia-Larana, et al.
Health and Quality of Life Outcomes|September 10, 2009
Valuation of transfusion-free living in MDS: results of health utility interviews with patientsAgota Szende, Caroline Schaefer, Thomas F Goss, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 10, 2022
Plasma microRNA vary in association with the progression of Alzheimer's diseaseDiane Guévremont, Helen Tsui, Robert Knight, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 16, 2011
Adjusting for patient crossover in clinical trials using external data: a case study of lenalidomide for advanced multiple myelomaK Jack Ishak, J Jaime Caro, Mark T Drayson, et al.
Journal of Cell Science|October 23, 2020
Cell Tracking Profiler - a user-driven analysis framework for evaluating 4D live-cell imaging dataClaire Mitchell, Lauryanne Caroff, Jose Alonso Solis-Lemus, et al.
Depression and Anxiety|February 14, 2015
Changes in neuropsychological function after treatment with metacognitive therapy or cognitive behavior therapy for depressionSamantha J Groves, Richard J Porter, Jennifer Jordan, et al.
The New England Journal of Medicine|October 6, 2006
Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletionAlan List, Gordon Dewald, John Bennett, et al.
The Journal of Surgical Research|December 20, 2021
Antigen Receptor T Cells (CAR-T) Effectively Control Tumor Growth in a Colorectal Liver Metastasis ModelLouis F Chai, John C Hardaway, Kara R Heatherton, et al.
Journal for Immunotherapy of Cancer|August 27, 2020
HITM-SURE: Hepatic immunotherapy for metastases phase Ib anti-CEA CAR-T study utilizing pressure enabled drug deliverySteven C Katz, Ashley E Moody, Prajna Guha, et al.
Pageof 7